NCT02557360View on ClinicalTrials.gov

Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Primary Biliary Cirrhosis
Interventions
DIETARY_SUPPLEMENT

S-adenosyl-L-methionine

Patients will be treated with S-adenosyl-L-methionine, tablets 800 mg twice a day (daily dosage 1600 mg) for six months

Trial Locations (2)

Unknown

Wunsch, Szczecin

Milkiewicz, Warsaw

All Listed Sponsors
collaborator

Laval University

OTHER

lead

Pomeranian Medical University Szczecin

OTHER

NCT02557360 - Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter